NCT00117039View on ClinicalTrials.gov

A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia

PHASE4CompletedINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

April 30, 2005

Conditions
AnemiaNeoplasms
Interventions
DRUG

Aranesp®

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00117039 - A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia | Biotech Hunter | Biotech Hunter